E. Cebeci Et Al. , "The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4, pp.189-194, 2019
Cebeci, E. Et Al. 2019. The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4 , 189-194.
Cebeci, E., Cakan, C., GÜRSU, M., Uzun, S., Karadag, S., Koldas, M., ... Calhan, T.(2019). The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4, 189-194.
Cebeci, Egemen Et Al. "The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4, 189-194, 2019
Cebeci, Egemen Et Al. "The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4, pp.189-194, 2019
Cebeci, E. Et Al. (2019) . "The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.127, no.4, pp.189-194.
@article{article, author={Egemen Cebeci Et Al. }, title={The Main Determinants of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, Obesity and Insulin Resistance}, journal={EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES}, year=2019, pages={189-194} }